Association between restless legs syndrome and migraine

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 5, 2010, Pages 473-475

  Silberstein, Stephen D ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; IRON; LEVODOPA;

COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CONTROL; DOPAMINE RECEPTOR BLOCKING; EDITORIAL; FIBROMYALGIA; GENETIC RISK; HEADACHE; HUMAN; IRON THERAPY; MIGRAINE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; THERAPY EFFECT; TRANSFORMED MIGRAINE; CLINICAL TRIAL; NOTE; PRIMARY HEADACHE;

CLINICAL TRIALS AS TOPIC; COMORBIDITY; DOPAMINE ANTAGONISTS; HEADACHE DISORDERS, PRIMARY; HUMANS; MIGRAINE DISORDERS; RESTLESS LEGS SYNDROME;

EID: 77952562254     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.200030     Document Type: Editorial

References (31)

1. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994;44:6-16.
2. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739-43.
3. Walters AS. Toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634-42.
4. Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology 1996;47:1435-1441. (Pubitemid 26422532)
5. Chokroverty S. Sleep disorders. In: Bradley WG, Daroff RB, Fenichel GM, et al, eds. Neurology in clinical practice. 3rd edn. Boston: Butterworth-Heinemann, 2000:1781-827.
6. Brodeur C, Montplaisir J, Godbout R, et al. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988;38:1845-8. (Pubitemid 19004577)
7. Walters AS, Hening JW, Kavey N, et al. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1988;24:455-8.
8. Trenkwalder C, Stiasny K, Pollmacher T, et al. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trail. Sleep 1995;18:681-8.
9. Wetter TC, Stiasny K, Winkelmann J, et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999;52:944-50.
10. Montplaisir J, Nicolas A, Denesle R, et al. Restless legs syndrome improved by pramipexole: a double-blind randomized trail. Neurology 1999;52:938-43. (Pubitemid 29161600)
11. Reuter I, Ellis CM, Chaudhuri KR. Nocturnal subcutaneous apomorphien infusion in Parkinson's disease and restless legs syndrome. Acta Neurol Scand 1999;100:163-7. (Pubitemid 29376827)
12. Ondo W. Ropinirole for restless legs syndrome. Mov Disord 1999;14:138-40.
13. Inoue Y, Mitani H, Nanba K, et al. Treatment of periodic leg movements disorder and restless legs syndrome with talipexole. Psychiatry Clin Neurosci 1999;53:283-5.
14. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999;52:932-7. (Pubitemid 29161599)
15. Staedt J, Stoppe G, Kogler A, et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2 receptor alteration. Eur Arch Psychiatry Clin Neurosci 1995;245:8-10.
16. O'keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Aging 1994;23:200-203.
17. Sachdev P. The neuropsychiatry of brain iron. J Neuropsychiatry Clin Neurosci 1993;5:18-29.
18. Ulfberg J, Nystrom B, Carter N, et al. Restless legs syndrome among working-aged women. Eur Neurol 2001;46:17-19.
19. Peres MF, Young WB, Kaup AO, et al. Fibromyalgia is common in patients with transformed migraine. Neurology 2001;57:1326-8.
20. Yunus MB. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Baillieres Clin Rheumatol 1994;8:811-37.
21. Yunus MB. Central sensitivity syndromes: a unified concept for fibromyalgia and other similar maladies. J Indian Rheum Assoc 2000;8:27-33.
22. Yunus MB. A comprehensive medical evaluation of patients with fibromyalgia syndrome. Rheum Dis Clin N Am 2002;28:201-17.
23. Young WB, Piovesan E, Biglan KM. Restless legs syndrome and drug-induced akathesia in headache patients. CNS Spectr 2003;6:450-6. (Pubitemid 36765012)
24. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-6.
25. Ekbom KA. Restless legs syndrome. Neurology 1960;10:868-73.
26. Rhode AM, Hösing VG, Happe S. Comorbidity of migraine and restless legs syndrome: a case control study. Cephalalgia 2007;27:1255-60.
27. d'Onofrio F, Bussone G, Cologno D, et al. Restless legs syndrome and primary headaches: a clinical study. Neurol Sci 2008;29 Suppl 1:S169-72.
28. Chen P-K, Fuh J-L, Chen S-P, et al. Association between Restless Legs Syndrome and Migraine. J Neurol Neurosurg Psychiatry 2010;81:524-8.
29. Ondo WG, He Y, Rajasekaran S, et al. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2009;15:154-8.
30. Clemens S, Rye D, Hochman S. Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006;67:125-30.
31. Charbit A, Holland PR, Goadsby PJ. Stimulation or lesioning of dopaminergic A11 cell group affects neuronal firing in the trigeminal nucleus caudalis. Cephalagia 2007;27:605.(Abstract).